首页> 外文期刊>Cureus. >Intraoperative Neuromonitoring for Cerebral Arteriovenous Malformation Embolization: A Propensity-Score Matched Retrospective Database Study
【24h】

Intraoperative Neuromonitoring for Cerebral Arteriovenous Malformation Embolization: A Propensity-Score Matched Retrospective Database Study

机译:脑动静脉畸形栓塞术中的术中神经监督:倾向评分匹配的回顾数据库研究

获取原文
获取外文期刊封面目录资料

摘要

Introduction The treatment of cerebral arteriovenous malformations (AVMs) may result in neurologic morbidity, particularly when an AVM is located in or adjacent to eloquent brain regions. Intraoperative neurophysiologic monitoring (IONM) may be utilized to reduce the risk of iatrogenic injury during endovascular AVM embolization; however, IONM for endovascular AVM embolization is not ubiquitously the standard of care. Methods Admissions for AVM embolization were assessed from the IBM MarketScan? Commercial and Medicare Supplemental databases (IBM Watson Health, Somers, NY). Inclusion criterion for patients was continuous enrollment six months before and after the index encounter. The use of IONM and presence of intracranial hemorrhage (ICH) were noted. Propensity-score matched cohorts with and without IONM were generated to minimize bias between treatment groups (adjusting for age, sex, and comorbidities). Results From 2007 to 2016, there were 16,279 patients diagnosed with cerebral AVM in the MarketScan database. Embolized patients were stratified into IONM and non-IONM cohorts; there were 357 patients in the IONM cohort and 1775 patients in the non-IONM cohort. Provider types were significantly different between cohorts (p0.005). Unruptured AVMs were significantly more likely to be embolized with adjunctive IONM (17.7%) compared to ruptured AVMs (7.9%) (p0.005). After balancing for baseline comorbidities, there were 266 patients in the IONM cohort, and 1347 patients in the non-IONM cohort. Among unruptured AVM patients, IONM was linked to a significantly shorter length of stay (2.72 versus 4.92 days; p0.005), significantly lower rates of complications within 30 days of discharge (0.00% versus 1.88%; p=0.038), and significantly lower total payment ($40,179 versus $50,844; p0.0001). Conclusion Endovascular embolization for unruptured AVMs performed with adjunctive IONM was associated with shorter length of stay, lower complication rates, and hospitalization costs.
机译:引言脑动静脉畸形(AVM)的治疗可能导致神经系统发病率,特别是当AVM位于雄性脑区域中或邻近的雄性脑区域时。可以利用术中神经生理监测(IONM)来降低血管内AVM栓塞期间的政治损伤的风险;然而,用于血管内AVM栓塞的IONM并不是普遍的护理标准。方法从IBM Marketscan评估AVM栓塞的入学?商业和医疗保险补充数据库(IBM Watson Health,Somers,NY)。纳入患者的标准在指数遭遇前后持续六个月持续入学。注意使用IONM和颅内出血(ICH)的存在。产生具有和不含IONM的倾向分数匹配的队列以最大限度地减少治疗组之间的偏差(调整年龄,性别和组合)。结果2007年至2016年,患有16,279名患者诊断患有Marketscan数据库中的脑AVM。将栓塞患者分层分层,对IONM和非OCOMM队列; INOMM队列中有357名患者和1775名非IONM队列患者。在队列之间提供者类型显着差异(P <0.005)。与破裂的AVM(7.9%)(P <0.005)相比,未破裂的AVM明显更容易被辅助IONM(17.7%)栓塞。对基线合并的平衡后,IONM队列中有266名患者,非IONM队列中的1347名患者。在未破裂的AVM患者中,IONM与保持率明显较短的逗留程度(2.72对4.92天; P <0.005),在排出后30天内显着降低并发症率(0.00%而与1.88%; P = 0.038),显着较低的总付款(40,179美元与50,844美元; P& 0.0001)。结论与辅助IONM进行的未破后AVM的血管内栓塞与较短的住宿时间,降低并发症率和住院费用相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号